Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
stereotactic body radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Prostate Cancer
1 trial -
stereotactic radiosurgery
United Therapeutics Europe Ltd
Head and Neck Cancer
1 trial -
steroid therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sudden Hearing Loss
1 trial -
substructure informed planning
United Therapeutics Europe Ltd
Brain Tumor
1 trial -
tacrolimus
The First People's Hospital of Lianyungang
Renal Transplantation
1 trial -
telemedically guided oropharyngeal + nasal (OP+N) self-sampling (GSS) and nasopharyngeal (NP) or OP+N sampling performed by health care professionals (HCP)
Praxis Precision Medicines
Telemedicine
1 trial -
telmisartan
The First People's Hospital of Lianyungang
Hypertension
1 trial -
tested formula with fiber
United Therapeutics Europe Ltd
Atopic Dermatitis
1 trial -
the absorbable hemostat and suture
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Ovarian Cyst Benign
1 trial -
the ginsenoside Rg3
The First People's Hospital of Lianyungang
Stage I Hepatocellular Carcinoma
1 trial -
the traditional Chinese medicine prescription ' Shenzhuo Decoction '
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diabetic Kidney Disease (DKD)
1 trial -
the usage of Olverembatinib combined with Inotuzumab Ozogamicin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Ph+ ALL
1 trial -
therapeutic progesterone
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
thyroxine
The First People's Hospital of Lianyungang
Hypothyroidism
1 trial -
traditional chinese medicine Xuanfei-Zhike formula
The First People's Hospital of Lianyungang
Cough Variant Asthma
1 trial -
transdermal nicotine patches
BRIGHT MINDS BIOSCIENCES INC.
Tobacco Use
1 trial -
vasoconstrictor and oxytocin treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy
1 trial -
vats
The First People's Hospital of Lianyungang
NSCLC
1 trial -
white wine
United Therapeutics Europe Ltd
Unspecified Adult Solid Tumor, Protocol Specific
1 trial -
xDRIVE Tumor Profiling
The First People's Hospital of Lianyungang
Cancer
1 trial -
zanubrutinib 160 mg BID orally
The First People's Hospital of Lianyungang
Primary Central Nervous System Lymphoma
1 trial -
zanubrutinib, bendamustine, and obinutuzumab
The First People's Hospital of Lianyungang
Follicular Lymphoma
1 trial -
zoledronate therapy
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
zuojinwan
The First People's Hospital of Lianyungang
Functional Dyspepsia
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources